AR and neoplasm: These in vivo studies revealed no difference in tumor growth due to AR expression or signaling; thus, we proceeded with vaccine studies using cell lines expressing AR-V7 as this is the most observed AR splice variant in mCRPC and produced the strongest induction of androgen signaling pathways (Figure S3).